Key facts
- Teal Health’s last known valuation is $48.0M (Jan 2025).
- It has raised $23.4M across 1 recorded rounds; the latest was Early Stage VC ($23.5M) in Nov 2024.
- Notable investors include MedTech Innovator, Felicis, Tribe Capital, Precursor Ventures, Forerunner Ventures — 19 tracked in total.
- Teal Health has filed 1 Form D with the SEC, most recently Jan 2025 ($23.5M sold to 74 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Teal Health
Funding rounds
1 roundsAbout Teal Health
Developer of at-home cervical cancer screening devices designed to provide a convenient and private alternative to traditional clinical screenings. The company offers a platform that includes an FDA-approved sampling device, virtual consultations with licensed providers, secure laboratory testing using the same primary human papillomavirus (HPV) test as clinical settings, an online portal for viewing results, and coordination of follow-up care, enabling women and healthcare providers to increase screening accessibility, improve early detection rates, and reduce barriers associated.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2018
- Employees
- 21
- Website
- getteal.com/
- Ownership
- Privately Held (backing)
Teal Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Teal Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Teal Health in its N-PORT filings yet. We sweep new filings monthly.